Astera Labs, Inc. (ALAB) Stock Price & Analysis
Astera Labs, Inc. (ALAB) closed at USD 257.82 on Thursday, October 22, 2026, down 11.11% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 290.06; the Oct 22, 2026 session ranged USD 254.72–278.94 on volume of 6,317,378 shares. Market capitalization is $44.73B, with a 52-week range of USD 97.89–499.48 (NMS). Source: Nexqual, retrieved October 23, 2026 at 10:03 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ALAB.md
Key facts (ALAB)
- Last four reported quarters (through Jun 30, 2026): revenue $1.20B, net income $369M (30.7% margin), free cash flow $277M (SEC filings).
- Valuation: P/E 121.1x (avg 136.3x at the last 1 fiscal year-ends).
- 1 of 80 tracked superinvestors hold ALAB (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.04 on a 1–5 scale) (26 analysts), mean target USD 388.36 (range 190–500).
- Total return with dividends: 1Y +57.5% vs S&P 500 +14.9%; 5Y +268.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 1.19, revenue estimate $551M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ALAB)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $79.9M | $116M | $396M | $853M | $1.20B |
| Gross profit | $58.7M | $79.8M | $303M | $645M | — |
| Operating income | -$60.2M | -$29.5M | -$116M | $173M | $273M |
| Net income | -$58.3M | -$26.3M | -$83.4M | $219M | $369M |
| EPS (diluted) | -$1.71 | -$0.71 | -$0.64 | $1.22 | — |
| Free cash flow | -$39.8M | -$15.5M | $102M | $282M | $277M |
| Gross margin | 73.5% | 68.9% | 76.4% | 75.7% | — |
| Operating margin | -75.4% | -25.5% | -29.3% | 20.3% | 22.8% |
| Net margin | -73.0% | -22.7% | -21.1% | 25.7% | 30.7% |
| Revenue growth | — | +45.0% | +242.2% | +115.1% | — |
| Cash + short-term investments | $76.1M | $149M | $914M | $1.19B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (ALAB)
P/E 121.1x · P/S 37.2x · P/FCF 161.7x · P/B 25.9x · FCF yield 0.62% · Earnings yield 0.83%
P/E at fiscal year-ends: Dec 2025 136.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (ALAB)
1 of 80 tracked investors hold ALAB. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lee Ainslie | Maverick Capital | 4.65% | $515M | Added +11.7% |
Analysts (ALAB)
Consensus Buy (mean 2.04 on a 1–5 scale), 26 analysts; mean target USD 388.36 (low 190, high 500).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | TD Cowen | Target lowered | Hold | $375 → $300 |
| 2026-08-17 | Northland Capital Markets | Upgrade | Market Perform → Outperform | $350 |
| 2026-08-05 | TD Cowen | Target lowered | Hold | $425 → $375 |
| 2026-08-05 | Morgan Stanley | Target raised | Overweight | $335 → $382 |
| 2026-08-05 | RBC Capital | Target raised | Outperform | $425 → $500 |
| 2026-08-05 | Evercore ISI Group | Target raised | Outperform | $297 → $452 |
| 2026-08-05 | Needham | Target raised | Buy | $260 → $425 |
| 2026-08-05 | Jefferies | Target raised | Buy | $270 → $450 |
| 2026-07-31 | Susquehanna | Target raised | Neutral | $230 → $275 |
| 2026-07-20 | Barclays | Target raised | Equal-Weight | $200 → $325 |
| 2026-07-13 | TD Cowen | Target raised | Hold | $225 → $425 |
| 2026-06-29 | UBS | Target raised | Neutral | $205 → $400 |
Total return (dividends reinvested) (ALAB)
| 1Y (from 2025-10-23) | 5Y (from 2024-03-18) | |
|---|---|---|
| Total return | +57.5% | +268.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +57.8% | +65.2% |
| Volatility (annualized) | 97.9% | 81.2% |
| Max drawdown | -48.3% (Jun 2026→Jul 2026) | -62.6% (Dec 2024→Mar 2025) |
ALAB revenue by product line (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Product | $852.5M | 100.0% | +116.9% |
| Total revenue | $852.5M | 100% | — |
ALAB revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| China | $152.7M | 38.9% | +158.6% |
| Singapore | $113.7M | 29.0% | +71.2% |
| Taiwan | $105.8M | 27.0% | +86.7% |
| Other | $14.7M | 3.7% | +94.1% |
| United States | $5.5M | 1.4% | +149.4% |
| Total revenue | $392.4M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
ALAB suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | TSMC (TSM) | “We currently partner with TSMC to manufacture our integrated circuits.” |
| Supplier | ASE Technology (ASX) | “We use Advanced Semiconductor Engineering and Amkor Technologies to assemble, package, and test our ICs.” |
| Supplier | Amkor Technology (AMKR) | “We use Advanced Semiconductor Engineering and Amkor Technologies to assemble, package, and test our ICs.” |
| Partner | Amazon (AMZN) | “On February 5, 2026, the Company entered into a Warrant Agreement with Amazon.com NV Investment Holdings LLC, to acquire up to an aggregate of 3,262,299 shares of common stock at an exercise price of $142.82 per share (the "2026 Warrant").” |
| Competitor | Broadcom (AVGO) | “Our principal competitors include Broadcom, Inc., Credo Technology Group Holding Ltd., Marvell Technology, Inc., Microchip Technology Inc., Montage Technology, Parade Technologies, Ltd., and Rambus, Inc.” |
| Competitor | Credo Technology (CRDO) | “Our principal competitors include Broadcom, Inc., Credo Technology Group Holding Ltd., Marvell Technology, Inc., Microchip Technology Inc., Montage Technology, Parade Technologies, Ltd., and Rambus, Inc.” |
| Competitor | Microchip Technology (MCHP) | “Our principal competitors include Broadcom, Inc., Credo Technology Group Holding Ltd., Marvell Technology, Inc., Microchip Technology Inc., Montage Technology, Parade Technologies, Ltd., and Rambus, Inc.” |
Quoted from the company's 10-K filed Feb 20, 2026.
Companies that name ALAB in their SEC reports
| Relationship to ALAB | Company | Filing | Sentence |
|---|---|---|---|
| customer | Credo Technology Group Holding Ltd (CRDO) | 10-K Jun 15, 2026 | “Marvell Technology, Inc. (Marvell) and Astera Labs, Inc. (Astera), as well as various cable and optical transceiver suppliers.” |
ALAB customer concentration
In the period ended Jun 30, 2026, 4 direct customers each accounted for at least 10% (29%, 25%, 15%, 13%) of revenue, per the company's 10-Q filed Aug 5, 2026. The company does not name them.
ALAB company outlook (results filed Aug 4, 2026)
- “Earnings Webcast and Conference Call Astera Labs will host a conference call to review its financial results for the second quarter of 2026 and to discuss our financial outlook today at 1:30 p.m.”
Quoted word-for-word from the SEC 8-K results press release.
ALAB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.19 | $0.79 | +51.2% | $550.8M | 20 |
| Next quarter (ends Dec 2026) | $1.42 | $0.93 | +52.9% | $655.7M | 20 |
| Current fiscal year (ends Dec 2026) | $4.03 | $3.01 | +33.8% | $1.91B | 21 |
| Next fiscal year (ends Dec 2027) | $6.40 | $4.53 | +41.3% | $2.98B | 23 |
ALAB options: expected move
Options price a move of about ±17.5% (±$44.72) by Nov 6, 2026, which includes earnings on Nov 3, 2026; the earnings reaction alone is priced at about ±10.2%. Over the last 8 reports the stock moved ±13.1% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 89.4% | ±10.6% |
| Nov 6, 2026 | 14 | 107.6% | ±17.5% |
| Nov 13, 2026 | 21 | 99.3% | ±19.5% |
| Nov 20, 2026 | 28 | 94.8% | ±21.3% |
| Nov 27, 2026 | 35 | 89.4% | ±22.4% |
| Dec 4, 2026 | 42 | 87.4% | ±23.9% |
| Dec 18, 2026 | 56 | 84.9% | ±26.9% |
| Jan 15, 2027 | 84 | 80.2% | ±31.0% |
30-day implied volatility 93.9% vs 89.4% realized over the last 30 trading days. Put/call ratio (volume) 0.77. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 10:03 UTC)
| Price | USD 257.82 |
|---|---|
| Change | ▼ 11.11% (down) |
| Previous Close | USD 290.06 |
| Open | USD 273.55 |
| Day Range | USD 254.72 – 278.94 |
| 52-Week Range | USD 97.89 – 499.48 |
| Volume | 6,317,378 shares |
| Market Cap | $44.73B |
| Exchange | NMS |
Technical Analysis (ALAB)
Nexqual's technical model rates ALAB "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.54 (neutral) |
| vs SMA50 | Below (USD 312.07) |
| MACD | -12.62 (negative) |
Analyst Ratings (ALAB)
Wall Street analysts rate ALAB "Buy" based on 26 analysts, with a mean price target of USD 388.36 (range USD 190–500), per Nexqual as of October 23, 2026 at 10:03 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 26 |
| Mean Target | USD 388.36 |
| High Target | USD 500 |
| Low Target | USD 190 |
| Buy / Hold / Sell | 18 / 8 / 0 |
Earnings (ALAB)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 1.19 |
| Revenue Estimate | $550.80M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.8 vs est 0.69 ▲ beat |
| 2026-03-31 | USD 0.61 vs est 0.54 ▲ beat |
| 2025-12-31 | USD 0.58 vs est 0.51 ▲ beat |
| 2025-09-30 | USD 0.49 vs est 0.39 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
Financials & Fundamentals (ALAB)
| Total Revenue | $1.20B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +104.50% |
| Gross Margin | +75.13% |
| Operating Margin | +22.74% |
| Profit Margin | +30.74% |
| ROE | +25.83% |
| Debt / Equity | 0.03 |
| Current Ratio | 10.05 |
| Total Cash | $1.25B |
| Total Debt | $44.41M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $276.68M (23.0% of revenue) |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
Financial Health Score (ALAB)
Nexqual rates Astera Labs, Inc.'s overall financial health "Strong" across five dimensions, as of October 23, 2026 at 10:03 UTC.
| Growth | Strong — Revenue +115% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 75%, operating 23% (last 12 months) |
| Balance Sheet | Strong — $1.25B cash vs $44M debt, net cash position |
| Cash Flow | Strong — FCF $277M (last 4 quarters to Jun 2026, SEC), 23% margin |
| Efficiency | Strong — ROE 26%, ROA 10.7% |
Ownership (ALAB)
| Insider Ownership | +10.32% |
|---|---|
| Institutional Ownership | +75.74% |
| Shares Outstanding | 173.49M |
| Float | 156.00M |
| Short % of Float | +6.94% |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
Leadership (ALAB)
Astera Labs, Inc. is led by Jitendra Mohan, Co-Founder, CEO & Executive Director, per Nexqual as of October 23, 2026 at 10:03 UTC.
| Co-Founder, CEO & Executive Director | Jitendra Mohan |
|---|---|
| Co-Founder, President, COO & Director | Sanjay Gajendra |
| Co-Founder & Chief Product Officer | Casey Morrison |
| Chief Financial Officer | Desmond Lynch |
| Senior Vice President of ASIC Engineering | Kalyan Mulam |
Major Backers & Investors (ALAB)
Notable institutional backers of Astera Labs, Inc. include FMR, LLC, Fidelity, Invesco, according to Nexqual as of October 23, 2026 at 10:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 14.32% |
| Fidelity | 5.96% |
| Invesco | 2.83% |
| Price (T.Rowe) Associates Inc | 1.39% |
| VanEck ETF Trust-VanEck Semiconductor ETF | 1.36% |
| Van Eck Associates Corporation | 1.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.43% |
| BlackRock | 7.89% |
| State Street | 2.12% |
| Geode Capital | 1.61% |
Source: Nexqual, October 23, 2026 at 10:03 UTC.
From Astera Labs, Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Building on years of experience with a singular focus on addressing connectivity challenges in data-centric systems, we have developed and deployed our leading Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure.
- For instance, we have developed multiple reference and/or commercial designs with different processor vendors.
- We enhance the value of our platform with our Interop Lab and by providing early interoperability reports with other data center infrastructure suppliers.
- Our deep market knowledge, successful execution track record, and customer trust allow us to identify opportunities for new product design wins as well as for our product roadmap.
Partnerships
- Based on trusted relationships with the leading hyperscalers and collaboration with data center infrastructure suppliers, our platform is designed to meet our customers' unique cloud scale requirements.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in existing tax laws, tax rules, or tax practices may adversely affect our financial results.
- Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.
- We may be subject to warranty claims and product liability.
- Litigation and other legal proceedings may adversely affect our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UMC | United Microelectronics Corpora | USD 18.53 | ▼ 6.51% |
| STM | STMicroelectronics N.V. | USD 44.09 | ▼ 7.04% |
| MCHP | Microchip Technology Incorporat | USD 74.52 | ▼ 3.41% |
| NXPI | NXP Semiconductors N.V. | USD 237.79 | ▼ 1.89% |
| MPWR | Monolithic Power Systems, Inc. | USD 1,167.93 | ▼ 8.99% |
| CRDO | Credo Technology Group Holding | USD 162.77 | ▼ 10.7% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:03 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt